SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Aardvark Adventures
DAVE 207.00-1.5%Dec 5 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ron who wrote (3904)1/23/2008 7:56:58 PM
From: ~digs  Read Replies (1) of 7944
 
Yes, Ron.. PTEC doing well, very much so..

here's another..

------------
[SMTS] SOMANETICS CORP > 22.52 +2.57 ( +12.88%) Open > 20.00 Volume > 502703

Somanetics Corporation engages in the development, manufacture, and marketing of medical devices primarily in the United States. It primarily offers INVOS System, a non-invasive patient monitoring system that provides continuous information about changes in blood oxygen saturation levels in patients with or at risk for restricted blood flow. The company's INVOS System has applications in various market segments, including cardiac and carotid artery surgery, pediatric and neonatal ICU, and diabetic patient surgeries. It also develops and markets the CorRestore system for use in cardiac repair and reconstruction, including heart surgeries called surgical ventricular restoration.

Wednesday January 23, 8:07 am ET
Somanetics Reports Record Net Revenues and Income Before Income Taxes for Fourth Quarter and Fiscal 2007
- Fiscal 2007 net revenues increased 34 percent to a record $38.6 million, including a 47 percent increase in fourth quarter revenues to a record $11.3 million.
- Gross margin was 88 percent for fiscal 2007.
- Fiscal 2007 income before income taxes increased 55 percent to a record $14.9 million. Fiscal 2007 net income was $9.7 million, or $0.67 per diluted share.
- Fourth quarter income before income taxes increased 126 percent to a record $4.5 million, and net income for the fourth quarter was $2.8 million, or $0.19 per diluted share.
- Somanetics provides guidance for fiscal 2008 of approximately $50 million in net revenues, 87 to 88 percent gross margin and income before income taxes in the range of $17 to $18 million.
biz.yahoo.com

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext